Amtagvi Granted Accelerated Approval for Unresectable or Metastatic Melanoma

The FDA granted accelerated approval to lifileucel (Amtagvi, Iovance Biotherapeutics), a tumor-derived autologous T ...

FEBRUARY 16, 2024